# Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect

> **NCT02644330** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Perimembranous Ventricular Septal Defect

## Interventions

- **PROCEDURE:** transthoracic device closure
- **PROCEDURE:** surgical repair

## Key facts

- **NCT ID:** NCT02644330
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644330, "Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02644330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*